Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508096 | SCV001714020 | uncertain significance | not provided | 2019-08-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002388566 | SCV002675066 | uncertain significance | Cardiovascular phenotype | 2019-07-16 | criteria provided, single submitter | clinical testing | The p.Q25004R variant (also known as c.75011A>G), located in coding exon 185 of the TTN gene, results from an A to G substitution at nucleotide position 75011. The glutamine at codon 25004 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |